BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6088468)

  • 1. Naltrexone in addicted business executives and physicians.
    Washton AM; Pottash AC; Gold MS
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):39-41. PubMed ID: 6088468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the National Institute on Drug Abuse in the development of naltrexone.
    Ginzburg HM; Glass WJ
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone in addicted physicians and business executives.
    Washton AM; Gold MS; Pottash AC
    NIDA Res Monogr; 1984; 55():185-90. PubMed ID: 6443377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience.
    Ling W; Wesson DR
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):46-8. PubMed ID: 6469936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    Adv Alcohol Subst Abuse; 1984; 3(3):41-9. PubMed ID: 6093484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone induction: psychologic and pharmacologic strategies.
    Kleber HD; Kosten TR
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):29-38. PubMed ID: 6469934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone: its clinical utility.
    Ginzburg HM
    Adv Alcohol Subst Abuse; 1985 Fall-1986 Winter; 5(1-2):83-101. PubMed ID: 3832903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS; Rawson RA; Cohen AJ; Mann A
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone: a clinical perspective.
    Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of naltrexone, a long-acting opiate antagonist.
    Crabtree BL
    Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone treatment in a jail work-release program.
    Brahen LS; Henderson RK; Capone T; Kordal N
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):49-52. PubMed ID: 6469937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.
    Kleber HD; Topazian M; Gaspari J; Riordan CE; Kosten T
    Am J Drug Alcohol Abuse; 1987; 13(1-2):1-17. PubMed ID: 3687878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone and clonidine: alternatives to methadone.
    Ginzburg HM
    Am Fam Physician; 1983 Nov; 28(5):100, 102. PubMed ID: 6637740
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
    Azatian A; Papiasvilli A; Joseph H
    J Addict Dis; 1994; 13(1):35-52. PubMed ID: 8018739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
    Fontaine E; Godfroid IO; Guillaume R
    Encephale; 2001; 27(2):187-93. PubMed ID: 11407272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of naltrexone to extinguish opioid-conditioned responses.
    O'Brien CP; Childress AR; McLellan AT; Ternes J; Ehrman RN
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):53-6. PubMed ID: 6381473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of naltrexone in addicted physicians and business executives.
    Washton AM; Gold MS; Pottash AC
    Adv Alcohol Subst Abuse; 1984; 4(2):89-96. PubMed ID: 6524509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.